Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization, Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells

Doxorubicin (DOX) is a chemotherapeutic agent is used for various cancer cells. To characterize the chemical structural components and metabolic inhibition, we applied a DOX to HCT116 colon cancer cells using an independent metabolites profiling approach. Chemical metabolomics has been involved in t...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Raja Ganesan, Vasantha-Srinivasan Prabhakaran, Abilash Valsala Gopalakrishnan
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2022-10-01
Reeks:	Metabolites
Onderwerpen:	HCT116 cells doxorubicin colorectal cancer NMR metabolomics metabolic profiling
Online toegang:	https://www.mdpi.com/2218-1989/12/11/1047
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!